GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » Capex-to-Revenue

Circa Group AS (OSL:CIRCA) Capex-to-Revenue : 590.60 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Circa Group AS Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Circa Group AS's Capital Expenditure for the three months ended in Mar. 2024 was kr-129.34 Mil. Its Revenue for the three months ended in Mar. 2024 was kr0.22 Mil.

Hence, Circa Group AS's Capex-to-Revenue for the three months ended in Mar. 2024 was 590.60.


Circa Group AS Capex-to-Revenue Historical Data

The historical data trend for Circa Group AS's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circa Group AS Capex-to-Revenue Chart

Circa Group AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
0.41 114.21 135.42 280.01

Circa Group AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.61 11.24 35.18 - 590.60

Competitive Comparison of Circa Group AS's Capex-to-Revenue

For the Biotechnology subindustry, Circa Group AS's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circa Group AS's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circa Group AS's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Circa Group AS's Capex-to-Revenue falls into.



Circa Group AS Capex-to-Revenue Calculation

Circa Group AS's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-215.889) / 0.771
=280.01

Circa Group AS's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-129.341) / 0.219
=590.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Circa Group AS  (OSL:CIRCA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Circa Group AS Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Circa Group AS's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Circa Group AS (OSL:CIRCA) Business Description

Traded in Other Exchanges
Address
Karenslyst alle 53, Oslo, NOR, 0279
Circa Group AS is a biotechnology company. The company is engaged in converting waste biomass into advanced biochemical materials. Its Furacell production process takes abundant waste biomass and makes a platform molecule, levoglucosenone.

Circa Group AS (OSL:CIRCA) Headlines

No Headlines